# Efficacy Study of Sunitinib and Everolimus (Rotational vs Sequential Arm) in Pats. With m Clear Cell Renal Cancer

> **NCT01784978** · PHASE2 · TERMINATED · sponsor: **Associació per a la Recerca Oncologica, Spain** · enrollment: 41 (actual)

## Conditions studied

- Metastatic Renal Cell Carcinoma

## Interventions

- **DRUG:** Sunitinib
- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT01784978
- **Lead sponsor:** Associació per a la Recerca Oncologica, Spain
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-02-12
- **Primary completion:** 2017-05-08
- **Final completion:** 2017-05-08
- **Target enrollment:** 41 (ACTUAL)
- **Why stopped:** Lack of recruitment
- **Last updated:** 2017-10-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01784978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01784978, "Efficacy Study of Sunitinib and Everolimus (Rotational vs Sequential Arm) in Pats. With m Clear Cell Renal Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01784978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*